Eagle Pharmaceuticals
EGRX
#8886
Rank
HK$0.43 B
Marketcap
HK$33.28
Share price
-0.23%
Change (1 day)
-72.30%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): HK$0.27 B

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are HK$0.27 B. In 2022 the company made an earning of HK$0.51 B an increase over its 2021 earnings that were of -HK$22.71 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) HK$0.27 B-45.63%
2022 HK$0.51 B-2361.45%
2021 -HK$22.71 M-111.53%
2020 HK$0.19 B2.31%
2019 HK$0.19 B-32.89%
2018 HK$0.28 B-50.35%
2017 HK$0.57 B38.63%
2016 HK$0.41 B1966.43%
2015 HK$20.15 M-111.46%
2014 -HK$0.18 B282.82%
2013 -HK$45.97 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$158.02 B 56,752.41%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$48.87 B 17,482.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$84.95 B 30,464.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$6.44 B 2,219.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
HK$27.47 B 9,785.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$70.07 B 25,109.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$50.04 B-18,101.07%๐Ÿ‡บ๐Ÿ‡ธ USA